D. Niese

781 total citations
43 papers, 573 citations indexed

About

D. Niese is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Transplantation. According to data from OpenAlex, D. Niese has authored 43 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Public Health, Environmental and Occupational Health and 10 papers in Transplantation. Recurrent topics in D. Niese's work include Renal Transplantation Outcomes and Treatments (10 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). D. Niese is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). D. Niese collaborates with scholars based in Germany, Switzerland and United States. D. Niese's co-authors include Paul Keown, Edgar A. Mueller, John M. Kovarik, Friedrich Raulf, Andreas Krause, Andreas Scherer, Alexander Korn, John R. Walker, I. Stroehmann and L. C. Paul and has published in prestigious journals such as The Lancet, Kidney International and The Journal of Urology.

In The Last Decade

D. Niese

40 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Niese Germany 12 285 161 152 83 76 43 573
G. Roussey France 13 225 0.8× 151 0.9× 83 0.5× 59 0.7× 83 1.1× 35 627
Eileen W. Tsai United States 14 324 1.1× 79 0.5× 143 0.9× 69 0.8× 77 1.0× 16 647
A. Wiland United States 10 371 1.3× 68 0.4× 347 2.3× 84 1.0× 30 0.4× 20 698
Florentine Garaix France 10 207 0.7× 118 0.7× 66 0.4× 73 0.9× 102 1.3× 25 437
Lewis Reisman United States 12 182 0.6× 71 0.4× 122 0.8× 83 1.0× 38 0.5× 29 391
Johan Noble France 16 340 1.2× 64 0.4× 171 1.1× 69 0.8× 129 1.7× 78 641
Enke Grabhorn Germany 17 166 0.6× 101 0.6× 549 3.6× 48 0.6× 47 0.6× 65 880
Mark Hathaway United Kingdom 18 300 1.1× 54 0.3× 326 2.1× 140 1.7× 178 2.3× 38 924
J. Xing United States 7 542 1.9× 73 0.5× 234 1.5× 111 1.3× 188 2.5× 12 726
J Bedrossian France 14 220 0.8× 32 0.2× 179 1.2× 89 1.1× 22 0.3× 28 546

Countries citing papers authored by D. Niese

Since Specialization
Citations

This map shows the geographic impact of D. Niese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Niese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Niese more than expected).

Fields of papers citing papers by D. Niese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Niese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Niese. The network helps show where D. Niese may publish in the future.

Co-authorship network of co-authors of D. Niese

This figure shows the co-authorship network connecting the top 25 collaborators of D. Niese. A scholar is included among the top collaborators of D. Niese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Niese. D. Niese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bruyère, Olivier, John А. Kanis, Maria Luisa Brandi, et al.. (2010). The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporosis International. 21(5). 713–722. 7 indexed citations
3.
Ewig, Santiago & D. Niese. (2008). Atypische Formen der AIDS-assoziierten Pneumocystis-carinii-Infektion. DMW - Deutsche Medizinische Wochenschrift. 116(9). 346–351.
4.
Scherer, Andreas, Andreas Krause, John R. Walker, et al.. (2003). Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation. 75(8). 1323–1330. 86 indexed citations
5.
6.
Frei, Ulrich, H.-H. Neumayer, B. Buchholz, D. Niese, & E. Mueller. (1998). Randomized, Double-Blind, One-Year Study of the Safety and Tolerability of Cyclosporine Microemulsion Compared With Conventional Cyclosporine in Renal Transplant Patients. The Journal of Urology. 160(6 Part 1). 2300–2300. 1 indexed citations
8.
Mueller, E., D. Niese, & B. Mellein. (1998). Cyclosporine microemulsion formulation (neoral) in transplantation: pharmacokinetic/pharmacodynamic relationships. Transplantation Proceedings. 30(5). 1694–1696. 6 indexed citations
9.
Kovarik, John M., Edgar A. Mueller, Françoise Richard, et al.. (1996). EVIDENCE FOR EARLIER STABILIZATION OF CYCLOSPORINE PHARMACOKINETICS IN DE NOVO RENAL TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATION. Transplantation. 62(6). 759–763. 60 indexed citations
10.
Niese, D.. (1995). A double-blind randomized study of sandimmun neoral versus sandimmun in new renal transplant recipients : results after 12 months. 27(2). 1849–1856. 10 indexed citations
11.
Niese, D.. (1995). A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.. PubMed. 27(2). 1849–56. 16 indexed citations
12.
Niese, D., et al.. (1994). Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients. Transplant International. 7(s1). 263–266. 40 indexed citations
13.
Ewig, Santiago, A. Steudel, Jennifer Vogel, & D. Niese. (1992). [Pulmonary Kaposi sarcoma in patients with AIDS].. PubMed. 46(2). 52–7. 1 indexed citations
14.
Ewig, Santiago, et al.. (1991). Pneumocystis carinii pleuropneumonia after aerosolized pentamidine prophylaxis. Infection. 19(6). 442–444. 3 indexed citations
15.
Kamradt, Thomas, D. Niese, K. E. Schneweis, et al.. (1989). Natural history of HIV-infection in hemophiliacs: Clinical, immunological, and virological findings. Journal of Molecular Medicine. 67(20). 1033–1041. 8 indexed citations
16.
Budde, Ulrich, et al.. (1987). FcR‐mediated clearance in thrombopenic and non‐thrombopenic patients with hemophilia A and possible relation of thrombopenia to HIV seropositivity. European Journal Of Haematology. 39(5). 440–446. 4 indexed citations
17.
Budde, Ulrich, et al.. (1986). Reticuloendothelial system Fc‐receptor function in patients with immune thrombocytopenia after treatment with high dose intravenous immunoglobulin. Scandinavian Journal of Haematology. 37(2). 125–129. 9 indexed citations
18.
Imbach, Paul, T.W. Jungi, S Barandun, et al.. (1983). INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA. The Lancet. 322(8349). 577–578. 15 indexed citations
19.
Niese, D., H. Grosse‐Wilde, Bo Dupont, et al.. (1978). Evidence for subtypic determinants in the HLA-DW3 cluster. Human Genetics. 43(1). 23–30. 7 indexed citations
20.
Sennekamp, J., D. Niese, I. Stroehmann, & Ch. Rittner. (1978). Pigeon breeders’lung lacking detectable antibodies. Clinical & Experimental Allergy. 8(3). 305–310. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026